HB-502
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HB-502, covering 2025-11-18 to 2025-11-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART [Phase 1]